SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?


To: Todd D. Wiener who wrote (290)6/4/1998 10:37:00 AM
From: Sigmund  Read Replies (1) | Respond to of 420
 
Thanks for your as usual very thoughtful analysis.

<<< Within the next 6 months, NOV expects to have plans for a capital refunding, such as replacing higher interest debt with convertible debt or preferred stock. NOV is looking at all options.<<<

That should improve both earnings and lower the PE on the spot.

This rumor might have been started by a short seller. It has all the markings of such to me.




To: Todd D. Wiener who wrote (290)6/5/1998 4:33:00 PM
From: Bill Boy  Read Replies (1) | Respond to of 420
 
Todd,

Thanks for sharing the info yesterday re your phone call with NOV. I had added to my position late last week based on some technical considerations that have led me to believe that an a-b-c type correction of the 12/96 to 10/97 upmove was about complete in both time and points in the the 10'ish area. However, those earnings rumors have been discomforting to say the least and it was good to at least hear the company refuting them. This good move today on the best upside volume in some time may indicate some better times ahead if NOV delivers and the general market doesn't get in the way too much.

Bill S.



To: Todd D. Wiener who wrote (290)6/15/1998 11:32:00 PM
From: Kelvin Taylor  Read Replies (3) | Respond to of 420
 
Todd-

At what price level does NOV become attractive? Technically, is the stock ready for a breakout on the upside?

Kelvin